Reports for TEVA CANADA LIMITED

Company Name

TEVA CANADA LIMITED

Totals

Shortage reports

2681

Actual shortage: 250 (9%)
Anticipated shortage: 0 (0%)
Avoided shortage: 9 (0%)
Resolved: 2422 (90%)

Discontinuation Reports

250

To be discontinued: 3 (1%)
Discontinued: 247 (99%)
Reversed: 0 (0%)

Late reports

330 (11%)

Overdue reports

25 (10%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-TAMOXIFEN 20MG TABLET Actual shortage 2024-02-09 2024-05-23 219038
TEVA-ESOMEPRAZOLE 20MG TABLET (DELAYED-RELEASE) Resolved 2024-03-07 2024-05-23 221552
TEVA-DONEPEZIL 5MG TABLET Resolved 2024-03-21 2024-05-23 222941
TEVA-TOPIRAMATE 25MG TABLET Resolved 2024-04-11 2024-05-23 224889
TEVA-LENOLTEC NO. 3 300MG 30MG 15MG TABLET Resolved 2024-04-18 2024-05-23 225477
TEVA-CEPHALEXIN 250 250MG POWDER FOR SUSPENSION Resolved 2024-02-29 2024-05-23 220977
TEVA-MOMETASONE 50MCG SPRAY, METERED DOSE Actual shortage 2024-01-11 2024-05-23 215760
TEVA-LACOSAMIDE 50MG TABLET Actual shortage 2024-03-18 2024-05-23 222575
TEVA-BUPRENORPHINE/NALOXONE 2MG 8MG TABLET Actual shortage 2024-03-07 2024-05-23 221537
ACT METHYLPHENIDATE ER 54MG TABLET (EXTENDED-RELEASE) Actual shortage 2024-05-16 2024-05-23 228143
TEVA-AMPHETAMINE XR 20MG CAPSULE (EXTENDED RELEASE) Actual shortage 2024-04-11 2024-05-23 224904
TEVA-DUTASTERIDE 0.5MG CAPSULE Actual shortage 2023-02-09 2024-05-23 184216
TEVA-SOLIFENACIN 10MG TABLET Actual shortage 2023-06-19 2024-05-23 195481
TEVA-SOLIFENACIN 10MG TABLET Actual shortage 2023-06-19 2024-05-23 195456
TEVA-SOLIFENACIN 5MG TABLET Actual shortage 2023-06-19 2024-05-23 195652
TEVA-SOLIFENACIN 5MG TABLET Actual shortage 2021-12-17 2024-05-23 151465
TEVA-QUETIAPINE XR 400MG TABLET (EXTENDED-RELEASE) Actual shortage 2024-03-18 2024-05-23 222572
TEVA-CLOPIDOGREL 300MG TABLET Actual shortage 2023-12-07 2024-05-23 212720
TEVA-TELMISARTAN HCTZ 25.0MG 80.0MG TABLET Actual shortage 2024-04-11 2024-05-23 224901
TEVA-CANDESARTAN 16MG TABLET Actual shortage 2024-02-22 2024-05-23 220267

Showing 1 to 20 of 2681

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
EPTIFIBATIDE INJECTION Discontinued 2020-02-13 2020-02-13 106170
TEVA-HYDROMORPHONE 8MG TABLET Discontinued 2020-02-13 2020-02-13 106167
TEVA-HYDROMORPHONE 4MG TABLET Discontinued 2020-02-13 2020-02-13 106164
TEVA-HYDROMORPHONE 2MG TABLET Discontinued 2020-02-13 2020-02-13 106161
TEVA-HYDROMORPHONE 1MG TABLET Discontinued 2020-02-13 2020-02-13 106158
GEMCITABINE FOR INJECTION Discontinued 2020-02-13 2020-02-13 106155
RATIO-SALBUTAMOL Discontinued 2020-02-13 2020-02-13 106151
RATIO-NYSTATIN 100000UNIT CREAM Discontinued 2020-02-13 2020-02-13 106148
TEVA-ATENOLOL 100MG TABLET Discontinued 2020-02-13 2020-02-13 106145
TEVA-ATENOLOL 50MG TABLET Discontinued 2020-02-13 2020-02-13 106142
TEVA-RANITIDINE Discontinued 2020-02-13 2020-02-13 106139
TEVA-RANITIDINE Discontinued 2020-02-13 2020-02-13 106136
TEVA-TRIMEL 400MG 80MG TABLET Discontinued 2020-02-13 2020-02-13 106133
TEVA-VENLAFAXINE XR 75MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-02-07 2020-02-08 105537
TEVA-LEVETIRACETAM 500MG TABLET Discontinued 2020-01-24 2020-01-24 104304
TEVA-QUININE 300MG CAPSULE Discontinued 2020-01-24 2020-01-24 104294
NOVAMOXIN 250MG CAPSULE Discontinued 2020-01-24 2020-01-24 104289
TEVA-ARIPIPRAZOLE 5MG TABLET Discontinued 2020-01-24 2020-01-24 104283
ACT OLANZAPINE ODT 15MG TABLET (ORALLY DISINTEGRATING) Discontinued 2020-01-24 2020-01-24 104277
TEVA-ARIPIPRAZOLE 5MG TABLET Discontinued 2020-01-24 2020-01-24 104263

Showing 81 to 100 of 250